NatImmune Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $9.4M

  • Investors
  • 2

NatImmune General Information

Description

Developer of protein-based therapeutic treatments designed to develop protein therapeutics within oncology and infectious diseases. The company engages in the treatment of cancer and infectious diseases through their targeted therapeutic treatment, offers protein therapeutics within oncology and infectious diseases, and more.

Contact Information

Website
www.natimmune.dk
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Symbion Science Park
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
+45 70
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Azanta
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Symbion Science Park
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
+45 70

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NatImmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 26-Jun-2009 $9.4M Completed Generating Revenue
4. Early Stage VC 03-Dec-2003 Completed Startup
3. Early Stage VC 15-Mar-2000 Completed Startup
2. Seed Round 01-Jan-2000 $2M $2M Completed Startup
1. University Spin-Out 01-Jan-2000 Completed Startup
To view NatImmune’s complete valuation and funding history, request access »

NatImmune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NatImmune Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dansk Erhvervsinvestering Venture Capital Minority
Kommunernes Pensionsforsikring Corporation Minority
Lønmodtagernes Dyrtidsfond (LD) Limited Partner Minority
Novo Holdings Corporate Venture Capital Minority
Sunstone Life Science Ventures Venture Capital Minority
To view NatImmune’s complete investors history, request access »

NatImmune Acquisitions (2)

NatImmune’s most recent deal was a Merger/Acquisition with Nya Hamlet Pharma. The deal was made on 18-Sep-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nya Hamlet Pharma 18-Sep-2006 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Hamlet BioPharma 07-Sep-2006 Merger/Acquisition Biotechnology
To view NatImmune’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

NatImmune FAQs

  • When was NatImmune founded?

    NatImmune was founded in 2000.

  • Where is NatImmune headquartered?

    NatImmune is headquartered in Copenhagen, Denmark.

  • What is the size of NatImmune?

    NatImmune has 5 total employees.

  • What industry is NatImmune in?

    NatImmune’s primary industry is Biotechnology.

  • Is NatImmune a private or public company?

    NatImmune is a Private company.

  • What is the current valuation of NatImmune?

    The current valuation of NatImmune is .

  • What is NatImmune’s current revenue?

    The current revenue for NatImmune is .

  • How much funding has NatImmune raised over time?

    NatImmune has raised $15.1M.

  • Who are NatImmune’s investors?

    Dansk Erhvervsinvestering, Kommunernes Pensionsforsikring, Lønmodtagernes Dyrtidsfond (LD), Novo Holdings, and Sunstone Life Science Ventures have invested in NatImmune.

  • When was NatImmune acquired?

    NatImmune was acquired on 26-Jun-2009.

  • Who acquired NatImmune?

    NatImmune was acquired by Azanta.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »